AAAAAA
Results: 1-25/409
Authors:
WEINBERG KI
Citation: Ki. Weinberg, INTRODUCTION - MOLECULAR-BASIS OF LYMPHOID IMMUNODEFICIENCY, Seminars in hematology, 35(4), 1998, pp. 280-281
Authors:
HONG R
Citation: R. Hong, THE DIGEORGE ANOMALY (CATCH 22, DIGEORGE VELOCARDIOFACIAL SYNDROME)/, Seminars in hematology, 35(4), 1998, pp. 282-290
Authors:
HERSHFIELD MS
Citation: Ms. Hershfield, ADENOSINE-DEAMINASE DEFICIENCY - CLINICAL EXPRESSION, MOLECULAR-BASIS, AND THERAPY, Seminars in hematology, 35(4), 1998, pp. 291-298
Authors:
URIBE L
WEINBERG KI
Citation: L. Uribe et Ki. Weinberg, X-LINKED SCID AND OTHER DEFECTS OF CYTOKINE PATHWAYS, Seminars in hematology, 35(4), 1998, pp. 299-309
Authors:
ELDER ME
Citation: Me. Elder, ZAP-70 AND DEFECTS OF T-CELL RECEPTOR SIGNALING, Seminars in hematology, 35(4), 1998, pp. 310-320
Authors:
FULEIHAN RL
Citation: Rl. Fuleihan, THE X-LINKED HYPERIMMUNOGLOBULIN-M SYNDROME, Seminars in hematology, 35(4), 1998, pp. 321-331
Authors:
OCHS HD
Citation: Hd. Ochs, THE WISKOTT-ALDRICH-SYNDROME, Seminars in hematology, 35(4), 1998, pp. 332-345
Authors:
KAPOOR N
CROOKS G
KOHN DB
PARKMAN R
Citation: N. Kapoor et al., HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR PRIMARY LYMPHOID IMMUNODEFICIENCIES, Seminars in hematology, 35(4), 1998, pp. 346-353
Authors:
WEINBERG KI
KOHN DB
Citation: Ki. Weinberg et Db. Kohn, GENE-THERAPY FOR CONGENITAL LYMPHOID IMMUNODEFICIENCY DISEASES, Seminars in hematology, 35(4), 1998, pp. 354-366
Authors:
KANTARJIAN H
Citation: H. Kantarjian, NEW ADVANCES IN THE TREATMENT OF HEMATOLOGIC MALIGNANCIES - FOCUS ON TOPOISOMERASE-I INHIBITORS - INTRODUCTION, Seminars in hematology, 35(3), 1998, pp. 1-2
Authors:
ARBUCK SG
TAKIMOTO CH
Citation: Sg. Arbuck et Ch. Takimoto, AN OVERVIEW OF TOPOISOMERASE-I - TARGETING AGENTS, Seminars in hematology, 35(3), 1998, pp. 3-12
Authors:
ABANG AM
Citation: Am. Abang, THE CLINICAL-PHARMACOLOGY OF TOPOISOMERASE-I INHIBITORS, Seminars in hematology, 35(3), 1998, pp. 13-21
Authors:
SEITER K
Citation: K. Seiter, INDUCTION OF APOPTOSIS BY TOPOTECAN - IMPLICATIONS FOR THE TREATMENT OF LEUKEMIA, Seminars in hematology, 35(3), 1998, pp. 22-25
Authors:
BERAN M
KANTARJIAN H
Citation: M. Beran et H. Kantarjian, TOPOTECAN IN THE TREATMENT OF HEMATOLOGIC MALIGNANCIES, Seminars in hematology, 35(3), 1998, pp. 26-31
Authors:
KRAUT EH
JU R
MULLER M
Citation: Eh. Kraut et al., THE USE OF TOPOISOMERASE-I INHIBITORS IN MULTIPLE-MYELOMA, Seminars in hematology, 35(3), 1998, pp. 32-38
Authors:
CHESON BD
Citation: Bd. Cheson, CHRONIC LYMPHOCYTIC-LEUKEMIA IN THE PURINE ANALOG ERA - NEW INSIGHTS AND CHALLENGES, Seminars in hematology, 35(3), 1998, pp. 1-2
Authors:
REED JC
Citation: Jc. Reed, MOLECULAR-BIOLOGY OF CHRONIC LYMPHOCYTIC-LEUKEMIA - IMPLICATIONS FOR THERAPY, Seminars in hematology, 35(3), 1998, pp. 3-13
Authors:
CHESON BD
Citation: Bd. Cheson, THERAPY FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC-LEUKEMIA - A REEVALUATION, Seminars in hematology, 35(3), 1998, pp. 14-21
Authors:
OBRIEN S
Citation: S. Obrien, CLINICAL CHALLENGES IN CHRONIC LYMPHOCYTIC-LEUKEMIA, Seminars in hematology, 35(3), 1998, pp. 22-26
Authors:
KEATING MJ
Citation: Mj. Keating, CHRONIC LYMPHOCYTIC-LEUKEMIA IN THE NEXT DECADE - WHERE DO WE GO FROMHERE, Seminars in hematology, 35(3), 1998, pp. 27-33
Authors:
KAUSHANSKY K
Citation: K. Kaushansky, INTRODUCTION - MEGAKARYOCYTE BIOLOGY AND PATHOPHYSIOLOGY, Seminars in hematology, 35(3), 1998, pp. 182-182
Authors:
BRUNO E
HOFFMAN R
Citation: E. Bruno et R. Hoffman, HUMAN MEGAKARYOCYTE PROGENITOR CELLS, Seminars in hematology, 35(3), 1998, pp. 183-191
Authors:
LONG MW
Citation: Mw. Long, MEGAKARYOCYTE DIFFERENTIATION EVENTS, Seminars in hematology, 35(3), 1998, pp. 192-199
Authors:
CRIPE LD
HROMAS R
Citation: Ld. Cripe et R. Hromas, MALIGNANT DISORDERS OF MEGAKARYOCYTES, Seminars in hematology, 35(3), 1998, pp. 200-209
Authors:
NAKASHIMA K
TAGA T
Citation: K. Nakashima et T. Taga, GP130 AND THE IL-6 FAMILY OF CYTOKINES - SIGNALING MECHANISMS AND THROMBOPOIETIC ACTIVITIES, Seminars in hematology, 35(3), 1998, pp. 210-221